TriGenex

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

Bifidobacterium infantis, Quantity: 3.2 billion CFU; Bifidobacterium longum, Quantity: 4.1 billion CFU; Bifidobacterium breve, Quantity: 4 billion CFU

제공처:

Biomedica Nutraceuticals Pty Ltd

INN (International Name):

Bifidobacterium breve,Bifidobacterium infantis,Bifidobacterium longum

약제 형태:

Capsule, hard

구성:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; tricalcium phosphate; tapioca starch; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum

관리 경로:

Oral

치료 징후:

Maintain/support general health and wellbeing ; Maintain/support healthy digestive system function ; Maintain/support healthy digestion ; Maintain/support digestive system health ; Maintain/support intestinal good/beneficial/friendly flora ; Helps restore good/beneficial/friendly intestinal/gut/bowel flora ; Maintain/support immune system health ; Maintain/support healthy immune system function

제품 요약:

Visual Identification: ;

승인 상태:

Licence status A

승인 날짜:

2017-06-30